Approval · Notice of Compliance 4045 · 1997
ZANTAC 75: Notice of Compliance 4045
Issued September 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4045
- Date
- September 15, 1997
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Rx to OTC switch
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANTAC 75 | 02230287 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB